Research Article
Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques
Table 3
Complete ranking of COVID-19 treatment options with VIKOR.
| Complete ranking | Alternatives | Qj | Sj | Rj |
| 1 | Plasma exchange | 0 | 5.1 | 0.92 | 2 | Favipravir | 0.013387978 | 5.345 | 0.92 | 3 | Intravenous immunoglobulin | 0.050273224 | 6.02 | 0.92 | 4 | Interleukin-1 blocker | 0.093442623 | 6.81 | 0.92 | 5 | Remdesivir | 0.113934426 | 7.185 | 0.92 | 6 | Interferon | 0.116393443 | 7.23 | 0.92 | 7 | Tocilizumab | 0.125136612 | 7.39 | 0.92 | 8 | Oseltamivir + hydroxychloroquine + azithromycin | 0.310382514 | 10.78 | 0.92 | 9 | Lopinavir/ritonavir | 0.337978142 | 11.285 | 0.92 | 10 | Oseltamivir + hydroxychloroquine | 0.449726776 | 13.33 | 0.92 | 11 | Hydroxychloroquine | 0.5 | 14.25 | 0.92 |
|
|